Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Taroni

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Cell Communication and Signaling : CCS|June 16, 2025
One gene, many phenotypes: the role of KIF5A in neurodegenerative and neurodevelopmental diseasesMarta Cozzi, Barbara Tedesco, Veronica Ferrari, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 11, 2011
Impaired vasoreactivity in mildly disabled CADASIL patientsJonica Campolo, Renata De Maria, Marina Frontali, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2025
Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598Giulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2021
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Neurology|May 13, 2014
Partial deletion of AFG3L2 causing spinocerebellar ataxia type 28Katrien Smets, Tine Deconinck, Jonathan Baets, et al.
Cells|April 25, 2020
Charcot-Marie-Tooth Type 2B: A New Phenotype Associated with a Novel <i>RAB7A</i> Mutation and Inhibited EGFR DegradationPaola Saveri, Maria De Luca, Veronica Nisi, et al.
EMBO Molecular Medicine|September 22, 2020
Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease miceGiulia Birolini, Marta Valenza, Eleonora Di Paolo, et al.
Parkinsonism & Related Disorders|April 8, 2020
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophyGiacomo Bitetto, Maria Chiara Malaguti, Roberto Ceravolo, et al.
Nature Communications|August 23, 2020
Frataxin gene editing rescues Friedreich's ataxia pathology in dorsal root ganglia organoid-derived sensory neuronsPietro Giuseppe Mazzara, Sharon Muggeo, Mirko Luoni, et al.
Stroke|September 4, 2014
Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trialRenata De Maria, Jonica Campolo, Marina Frontali, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Cell Communication and Signaling : CCS|June 16, 2025
One gene, many phenotypes: the role of KIF5A in neurodegenerative and neurodevelopmental diseasesMarta Cozzi, Barbara Tedesco, Veronica Ferrari, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 11, 2011
Impaired vasoreactivity in mildly disabled CADASIL patientsJonica Campolo, Renata De Maria, Marina Frontali, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2025
Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598Giulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2021
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Neurology|May 13, 2014
Partial deletion of AFG3L2 causing spinocerebellar ataxia type 28Katrien Smets, Tine Deconinck, Jonathan Baets, et al.
Cells|April 25, 2020
Charcot-Marie-Tooth Type 2B: A New Phenotype Associated with a Novel <i>RAB7A</i> Mutation and Inhibited EGFR DegradationPaola Saveri, Maria De Luca, Veronica Nisi, et al.
EMBO Molecular Medicine|September 22, 2020
Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease miceGiulia Birolini, Marta Valenza, Eleonora Di Paolo, et al.
Parkinsonism & Related Disorders|April 8, 2020
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophyGiacomo Bitetto, Maria Chiara Malaguti, Roberto Ceravolo, et al.
Nature Communications|August 23, 2020
Frataxin gene editing rescues Friedreich's ataxia pathology in dorsal root ganglia organoid-derived sensory neuronsPietro Giuseppe Mazzara, Sharon Muggeo, Mirko Luoni, et al.
Stroke|September 4, 2014
Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trialRenata De Maria, Jonica Campolo, Marina Frontali, et al.
Pageof 21